{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:10:53Z","timestamp":1781291453884,"version":"3.54.1"},"reference-count":70,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Salivary gland carcinomas (SGCs) represent a group of rare tumors, with complete surgical resection being the main treatment option. Therapeutic armory for cases of locally aggressive, recurrent, and\/or metastatic SGCs, though, remains poor since they exhibit high rates of resistance to systematic therapy. Angiogenesis is considered one of the contemporary hallmarks of cancer and anti-angiogenic factors have already been approved for the treatment of several cancer types. This review aims to summarize, in a histotype-specific manner, the most current available data on the angiogenic factors implicated in SGC angiogenesis, in order to highlight the differences between the most common SGC histotypes and the factors that may have a potential role as therapeutic targets.<\/jats:p>","DOI":"10.3390\/ijms21249335","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T09:17:04Z","timestamp":1607419024000},"page":"9335","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Impact of Angiogenesis in the Most Common Salivary Gland Malignant Tumors"],"prefix":"10.3390","volume":"21","author":[{"given":"Despoina","family":"Pouloudi","sequence":"first","affiliation":[{"name":"First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristoteles","family":"Sotiriadis","sequence":"additional","affiliation":[{"name":"First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Theodorakidou","sequence":"additional","affiliation":[{"name":"First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Sarantis","sequence":"additional","affiliation":[{"name":"Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Pergaris","sequence":"additional","affiliation":[{"name":"First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1369-8201","authenticated-orcid":false,"given":"Michalis V.","family":"Karamouzis","sequence":"additional","affiliation":[{"name":"Molecular Oncology Unit, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Theocharis","sequence":"additional","affiliation":[{"name":"First Department of Pathology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5604\/01.3001.0009.8412","article-title":"Increase in the incidence of parotid gland tumors in the years 2005\u20132014","volume":"71","author":"Kolebacz","year":"2017","journal-title":"Otolaryngol. Pol. Pol. Otolaryngol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"872982","DOI":"10.5402\/2012\/872982","article-title":"Review of salivary gland neoplasms","volume":"2012","author":"To","year":"2012","journal-title":"ISRN Otolaryngol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sentani, K., Ogawa, I., Ozasa, K., and Sadakane, A. (2019). Characteristics of 5015 Salivary Gland Neoplasms Registered in the Hiroshima Tumor Tissue Registry over a Period of 39 Years. J. Clin. Med., 8.","DOI":"10.3390\/jcm8050566"},{"key":"ref_4","first-page":"46","article-title":"Histopathological study of salivary gland tumors","volume":"21","author":"Bobati","year":"2017","journal-title":"JOMFP"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/00016489.2018.1455108","article-title":"Clinicopathologic analysis of 2736 salivary gland cases over a 11-year period in Southwest China","volume":"138","author":"Shen","year":"2018","journal-title":"Acta Oto-Laryngol."},{"key":"ref_6","unstructured":"El-Naggar, A.K., Chan, J.K.C., Rubin Grandis, J., Takata, T., and Slootweg, P.J. (2017). WHO Classification of Head and Neck Tumours."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.21873\/anticanres.13158","article-title":"Survival Probabilities Related to Histology, Grade and Stage in Patients with Salivary Gland Tumors","volume":"39","author":"Israel","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.18632\/oncotarget.13952","article-title":"Management of salivary gland carcinomas\u2014A review","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41199-016-0011-z","article-title":"Systemic therapy for recurrent or metastatic salivary gland malignancies","volume":"1","author":"Chintakuntlawar","year":"2016","journal-title":"Cancers Head Neck"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.oraloncology.2016.12.016","article-title":"Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?","volume":"66","author":"Alfieri","year":"2017","journal-title":"Oral Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2897827","DOI":"10.1155\/2018\/2897827","article-title":"A Review of Selected Factors of Salivary Gland Tumour Formation and Malignant Transformation","volume":"2018","author":"Sowa","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: Molecular pathways and therapeutic targets","volume":"17","author":"Weis","year":"2011","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127170","DOI":"10.1155\/2013\/127170","article-title":"Angiogenesis and its therapeutic opportunities","volume":"2013","author":"Yoo","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_14","first-page":"1016","article-title":"Revisiting the hallmarks of cancer","volume":"7","author":"Fouad","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/14728222.2018.1513494","article-title":"Neovascularization: An attractive but tricky target in thyroid cancer","volume":"22","author":"Tasoulas","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_16","first-page":"15","article-title":"Angiogenesis in cancer - general pathways and their therapeutic implications","volume":"19","author":"Dimova","year":"2014","journal-title":"JBUON"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.1095","article-title":"Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies","volume":"188","author":"Fonsatti","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/14728222.2015.1016424","article-title":"Angiogenesis in salivary gland tumors: From clinical significance to treatment","volume":"19","author":"Theocharis","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.17219\/acem\/64876","article-title":"Expression of VEGF(1)(6)(5)b, VEGFR1, VEGFR2 and CD34 in benign and malignant tumors of parotid glands","volume":"27","author":"Blochowiak","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in Signaling and Disease: Beyond Discovery and Development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1471-2407-9-391","article-title":"Assessment of angiogenesis by CD105 antigen in epithelial salivary gland neoplasms with diverse metastatic behavior","volume":"9","author":"Cardoso","year":"2009","journal-title":"BMC Cancer"},{"key":"ref_22","first-page":"5155","article-title":"Expression of Ki67 and CD105 as proliferation and angiogenesis markers in salivary gland tumors","volume":"13","author":"Tadbir","year":"2012","journal-title":"APJCP"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.surge.2012.07.004","article-title":"An analysis of microvessel density in salivary gland tumours: A single centre study","volume":"11","author":"Dhanuthai","year":"2013","journal-title":"Surgeon"},{"key":"ref_24","first-page":"30","article-title":"Immunohistochemical analysis of CD34 expression in salivary gland tumors","volume":"19","author":"Moghadam","year":"2015","journal-title":"JOMFP"},{"key":"ref_25","first-page":"37","article-title":"Neoangiogenesis in Benign and Malignant Salivary Gland Tumors","volume":"7","author":"Aminishakib","year":"2018","journal-title":"Gums Dent"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00428-008-0664-z","article-title":"Angiogenesis in salivary carcinomas with and without myoepithelial differentiation","volume":"453","author":"Costa","year":"2008","journal-title":"Virchows Arch."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1600-0714.2009.00810.x","article-title":"Morphometric analysis of CD34-positive vessels in salivary gland adenoid cystic and mucoepidermoid carcinomas","volume":"38","author":"Luukkaa","year":"2009","journal-title":"J. Oral Pathol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/apm.12160","article-title":"Vascular endothelial growth factor (VEGF) expression and microvascular density in salivary gland tumours","volume":"122","author":"Faur","year":"2014","journal-title":"APMIS"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1600-0714.2010.00980.x","article-title":"Vascular endothelial growth factor and thymidine phosphorylase expression in salivary gland tumors with distinct metastatic behavior","volume":"40","author":"Lima","year":"2011","journal-title":"J. Oral Pathol. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1158\/1078-0432.CCR-05-0241","article-title":"Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: Correlations with the angiogenesis and clinical outcome","volume":"11","author":"Zhang","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/SCS.0b013e3181f43f7e","article-title":"Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: A correlation with microvessel density","volume":"21","author":"Huang","year":"2010","journal-title":"J. Craniofacial Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.oraloncology.2010.08.008","article-title":"Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: Correlation with tumor progression and patients\u2019 prognosis","volume":"46","author":"Yang","year":"2010","journal-title":"Oral Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0714.1999.tb02035.x","article-title":"Expression of p53 oncoprotein increases intratumoral microvessel formation in human salivary gland carcinomas","volume":"28","author":"Doi","year":"1999","journal-title":"J. Oral Pathol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1034\/j.1600-0714.2003.00073.x-i1","article-title":"Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis","volume":"32","author":"Lim","year":"2003","journal-title":"J. Oral Pathol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.joms.2017.08.038","article-title":"The Neuropilins and Their Ligands in Hematogenous Metastasis of Salivary Adenoid Cystic Carcinoma-An Immunohistochemical Study","volume":"76","author":"Ni","year":"2018","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.prp.2010.08.001","article-title":"Expression of Neuropilin-2 in salivary adenoid cystic carcinoma: Its implication in tumor progression and angiogenesis","volume":"206","author":"Cai","year":"2010","journal-title":"Pathol. Res. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.joms.2012.10.026","article-title":"EphA2\/ephrinA1 mRNA expression and protein production in adenoid cystic carcinoma of salivary gland","volume":"71","author":"Shao","year":"2013","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s10266-017-0326-1","article-title":"Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland","volume":"106","author":"Ono","year":"2018","journal-title":"Odontology"},{"key":"ref_39","first-page":"764","article-title":"Inhibition of mTOR reduce Stat3 and PAI related angiogenesis in salivary gland adenoid cystic carcinoma","volume":"4","author":"Yu","year":"2014","journal-title":"Am. J. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.3892\/mmr.2015.3815","article-title":"Role of hypoxia-inducible factor-1\u03b1 and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.7150\/thno.19712","article-title":"Epiregulin Promotes Lung Metastasis of Salivary Adenoid Cystic Carcinoma","volume":"7","author":"Yang","year":"2017","journal-title":"Theranostics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s13277-012-0552-7","article-title":"Density of mast cells and microvessels in minor salivary gland tumors","volume":"34","author":"Vidal","year":"2013","journal-title":"Tumour Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.prp.2017.10.012","article-title":"MicroRNAs expression pattern related to mast cell activation and angiogenesis in paraffin-embedded salivary gland tumors","volume":"213","author":"Santos","year":"2017","journal-title":"Pathol. Res. Pract."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zhang, J., and Peng, B. (2007). In vitro angiogenesis and expression of nuclear factor kappaB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic Carcinoma. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-95"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2184.2009.00588.x","article-title":"NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro","volume":"42","author":"Zhang","year":"2009","journal-title":"Cell Prolif."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00405-014-3053-z","article-title":"Salivary mucoepidermoid carcinoma revisited","volume":"272","author":"Rodrigo","year":"2015","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1600-0714.2012.01153.x","article-title":"Angiogenesis and lymphangiogenesis in mucoepidermoid carcinoma of minor salivary glands","volume":"41","author":"Florencio","year":"2012","journal-title":"J. Oral Pathol. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/cncr.22573","article-title":"Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: Correlation with vascular endothelial growth factor, microvessel density, and clinical outcome","volume":"109","author":"Shi","year":"2007","journal-title":"Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1601-0825.2011.01813.x","article-title":"Association of clinicopathologic parameters with the expression of inducible nitric oxide synthase and vascular endothelial growth factor in mucoepidermoid carcinoma","volume":"17","author":"Liang","year":"2011","journal-title":"Oral Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1074\/jbc.M110354200","article-title":"Caveolin-1 expression enhances endothelial capillary tubule formation","volume":"277","author":"Liu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00428-007-0438-z","article-title":"Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma","volume":"451","author":"Soares","year":"2007","journal-title":"Virchows Arch."},{"key":"ref_52","first-page":"275","article-title":"Acinic cell carcinoma of the salivary glands: An immunohistochemical study of angiogenesis in 12 cases","volume":"54","author":"Margaritescu","year":"2013","journal-title":"Rom. J. Morphol. Embryol. Rev. Roum. Morphol. Embryol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","volume":"35","author":"Wang","year":"2015","journal-title":"Semin Cancer Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10456-017-9552-y","article-title":"Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?","volume":"20","author":"Ramjiawan","year":"2017","journal-title":"Angiogenesis"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MOO.0000000000000347","article-title":"Adenoid cystic carcinoma evaluation and management: Progress with optimism!","volume":"25","author":"Bradley","year":"2017","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/jpet.110.167692","article-title":"Mammalian target of rapamycin pathway promotes tumor-induced angiogenesis in adenoid cystic carcinoma: Its suppression by isoliquiritigenin through dual activation of c-Jun NH2-terminal kinase and inhibition of extracellular signal-regulated kinase","volume":"334","author":"Sun","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1158\/1535-7163.MCT-05-0228","article-title":"Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model","volume":"5","author":"Younes","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1158\/1078-0432.CCR-08-0245","article-title":"Vandetanib inhibits growth of adenoid cystic carcinoma in an orthotopic nude mouse model","volume":"14","author":"Choi","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1200\/JCO.2005.04.192","article-title":"Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: Pharmacokinetic and clinical results","volume":"23","author":"Rugo","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1093\/annonc\/mdw287","article-title":"A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma","volume":"27","author":"Ho","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Locati, L.D., and Cavalieri, S. (2019). Phase II trial with axitinib in recurrent and\/or metastatic salivary gland cancers of the upper aerodigestive tract. Head Neck.","DOI":"10.1002\/hed.25891"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/annonc\/mdr522","article-title":"A phase II study of sunitinib in recurrent and\/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: Current progress and challenges in evaluating molecularly targeted agents in ACC","volume":"23","author":"Chau","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/hed.23577","article-title":"Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck","volume":"37","author":"Thomson","year":"2015","journal-title":"Head Neck"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejca.2016.09.022","article-title":"A phase II study of sorafenib in recurrent and\/or metastatic salivary gland carcinomas: Translational analyses and clinical impact","volume":"69","author":"Locati","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Guigay, J., Bidault, F., Fayette, J., Even, C., Cupissol, D., Rolland, F., Peyrade, F., Laguerre, B., Le Tourneau, C., and Zanetta, S. (2016). Pazopanib in patients with progressive recurrent or metastatic (R\/M) salivary gland carcinoma (SGC): Further evaluation of efficacy including tumor growth rates (GR) analysis. H&N Unicancer Group PACSA trial with the REFCOR. Ann. Oncol., 27.","DOI":"10.1093\/annonc\/mdw376.38"},{"key":"ref_66","first-page":"1529","article-title":"Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma","volume":"37","author":"Tchekmedyian","year":"2019","journal-title":"J. Clin. Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/annonc\/mdv537","article-title":"Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors","volume":"27","author":"Wong","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1200\/JCO.2016.34.15_suppl.6096","article-title":"Phase II study of regorafenib in progressive, recurrent\/metastatic adenoid cystic carcinoma","volume":"34","author":"Ho","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1158\/1078-0432.CCR-16-2942","article-title":"A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma","volume":"23","author":"Dillon","year":"2017","journal-title":"J. Clin. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/cncr.29401","article-title":"Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma","volume":"121","author":"Keam","year":"2015","journal-title":"Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/24\/9335\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:13Z","timestamp":1760179333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/24\/9335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,8]]},"references-count":70,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ijms21249335"],"URL":"https:\/\/doi.org\/10.3390\/ijms21249335","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,8]]}}}